Implications and Opportunities of Applying QbD Principles to Analytical Measurements
The authors present two concepts to improve robustness and facilitate continuous improvement in analytical methods.
The merits of applying quality by design (QbD) to pharmaceutical products and processes is a topic of significant mutual interest to both pharmaceutical manufacturers and regulatory agencies. The pharmaceutical industry is currently embracing QbD concepts to help improve the robustness of manufacturing processes and to facilitate continuous improvement strategies to shape and enhance product quality and manufacturing productivity. As such, both industry and regulators recognize the benefits of adopting a QbD approach to drug-product development and manufacture, with key concepts described in International Conference on Harmonization (ICH) guidelines Q8(R1) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System.
Columnists
Outsourcing
Commercializing Cell Therapies: Lonza’s Eytan Abraham on Challenges and Rewards
Better equipment and automated processes will be key. So, too, will the right way of approaching outsourcing relationships.
Tech Ops for Hire
As CMOs shed their old toll processing role, sponsors can expect the right questions, proactive communication, and a firm grasp of risk management and tech transfer from contract service providers.
Webcasts
- Enhancing Quality and Process Efficiency Using Continuous Manufacturing Technology for Drug Substance and Drug Product
- Safe and Cost-Effective Capsule Filling for Pre-Clinical and First-in-Man Studies
- Maximizing Roller Compaction Benefits with Proper Excipient Selection
- Developing a Comprehensive Tool Kit for Microbial Identification
Sponsored Links
